Plain English Summary
Background and study aims
Autism is a lifelong condition that affects the way that a person communicates and relates to others. It is a spectrum condition, which means that the level of disability is spread across a wide range, from almost unnoticeable to completely debilitating. In general however, the difficulties sufferers experience tend to fall into social communication (speech and body language), social interaction (recognising and expressing emotions) and social imagination (being able to understand and predict other people’s behaviour). Children with autism often find it difficult to transfer skills learned in one setting to another. A previous study (the Preschool Autism Communication Trial, PACT) showed that in a clinical setting it was possible to help improve communication between parents and child however these improvements were less obvious in other settings. The aim of this study is to test ways to transfer the child’s communication gains into everyday home and education settings.
Who can participate?
Autistic children aged between 2 and 11 years.
What does the study involve?
This project is split into two phases. In the first phase, all participants receive the PACT-G therapy. This therapy involves coaching the parents in ways of interacting with their child. This takes place over a number of sessions, and is accompanied by sessions in educational settings (preschool or school) with educational staff. This part of the project is to find out whether schools are able take part and how easy it is to recruit participants for the study. In the second phase of the project, participants are randomly allocated to one of two groups. Those in the first group take part in the PACT-G therapy and those in the second group continue as usual, with no additional therapy. Children are assessed, and parents and teachers complete a number of questionnaires at the start, middle (7 months) and end (11 months) of the treatment.
What are the possible benefits and risks of participating?
Participants may benefit from improved communication abilities within different settings. There are no notable risks involved with taking part in this study.
Where is the study run from?
The study is run by University of Manchester and takes place in participants homes and schools across Newcastle, Manchester and London (UK)
When is the study starting and how long is it expected to run for?
February 2016 to July 2019
Who is funding the study?
National Institute for Health Research (UK)
Who is the main contact?
Ms Jo Lowe
Trial website
Additional identifiers
EudraCT number
ClinicalTrials.gov number
Protocol/serial number
20208
Study information
Scientific title
Paediatric Autism Communication Trial – Generalised (PACT-G)
Acronym
Study hypothesis
External pilot phase:
The aim of the external pilot phase is to:
1. Demonstrate schools’ willingness and ability to engage with the study
2. Demonstrate the ability to recruit and retain participants
Full randomised controlled trial:
The aim of this study is to test an intervention designed systematically to promote generalisation of previously demonstrated clinic-assessed treatment gains into home and school contexts.
Hypotheses:
1. The intervention will show the added efficacy and cost-effectiveness of preschool and school-age autism outcomes in home, school and research settings compared to treatment as usual
2. There will be an increase in the generalisation of acquired communication across contexts and persons, shown by mediation and the mechanistic study
Ethics approval
North West - Greater Manchester Central Research Ethics Committee, 28/01/2016, 15/NW/0912
Study design
External pilot phase:
Non-randomised feasibility study
Full randomised controlled trial:
Multi-centre randomised controlled trial
Primary study design
Interventional
Secondary study design
Randomised controlled trial
Trial setting
Other
Trial type
Treatment
Patient information sheet
Not available in web format, please use the contact details below to request a patient information sheet
Condition
Topic: Children, Mental Health; Subtopic: Children (all Diagnoses), Mental Health (Autism spectrum disorders); Disease: All Diseases, Autism spectrum disorders
Intervention
External pilot phase:
All participants receive the PACT-G therapy (see below)
Randomised controlled trial:
Participants are randomised to receive the PACT-G therapy (see below) or treatment as usual. Both groups will have a pre-randomisation baseline assessment, a mid-point (after approx 7 months) and end-point assessment (after approx 11 months).
Detail of the PACT-G intervention
PACT-G therapy is an enhancement of the original clinic-based PACT therapy. This is a ‘parent-mediated’ therapy in which caregivers are coached, using video-feedback, to interact with their child using evidence-based strategies that facilitate communication development in the child.
Parent sessions: Parents will receive 12 intervention sessions. Prior to starting the intervention, a home visit is conducted to introduce the intervention to the parents, explore the family context and set expectations. Where feasible the first two sessions are delivered in a clinic, allowing the parent to learn early strategies in a controlled environment with a set of toys specially selected to facilitate interaction. Subsequent sessions are a mix of home based sessions and Skype/telephone-delivered consultation. Each parent session begins with a discussion of progress made since the last session. The parent and therapist then watch a 5-minute video, either a video made by the therapist of the parent and child in play or a parent-made video of a home based routine, such as mealtime. The therapist facilitates the parent to identify actions that lead to child communication and to adopt PACT-G strategies in their interaction with the child. Parents are assisted to set goals for themselves, based on the interaction strategies discussed. They are asked to practice these daily, initially in a half hour ‘special time’, but eventually during naturalistic opportunities throughout the day.
Education setting sessions: Therapy in the educational setting begins 1 - 2 months after the parent has commenced therapy, with a start time integrating into the school term schedule. In the education setting PACT-G sessions will be delivered to trained learning support assistants (LSA), who are additional staff with a specific remit to attend to the child’s special needs and thus with dedicated individual time in the classroom or nursery. LSAs and other education staff receive an initial training session to introduce them to PACT-G therapy. The education-based intervention then consists of therapist-LSA sessions that mirror the therapist-parent sessions in the home. Videos are made of the LSA and the child and are used to coach the LSA in the use of appropriate PACT-G strategies. The LSA then implements these with the child daily in class time. There are 12 therapist-LSA sessions over 6 months, alternating in-school visits and skype/telephone consultation. PACT-G strategies will also be integrated in a complementary way with other communication strategies that may already be in use in the school.
Collaboration between parent and educational staff: Importantly, the separate therapeutic work with parents and LSAs described above will be supplemented with a schedule of joint parent-LSA meetings to support the work and ensure consistent use of strategies across home and education settings. The meetings will use the manualised technique of ‘Structured Conversation with Parents’ (SCP). Meetings are structured around ‘explore’, ‘focus’, ‘plan’ and ‘review’ stages, which allow the LSA and parent to share experiences and maximize intervention consistency.
Intervention type
Other
Phase
Drug names
Primary outcome measures
External pilot phase:
1.School engagement rate is determined by the total number of schools which have signed up to participate at the end of pilot phase, i.e. 6 months
2.Family recruitment rate is determined by the total number of families which have consented up to participate at the end of pilot phase, i.e. 6 months
Main randomised controlled trial:
Efficacy of the PACT-G therapy, which is assessed at mid-point (approx 6 - 8 months) and end-point (approx 11 months), with exact assessment tools to be determined during the external pilot phase.
Secondary outcome measures
Not provided at time of registration
Overall trial start date
01/02/2016
Overall trial end date
30/07/2019
Reason abandoned
Eligibility
Participant inclusion criteria
1. Child between 2 and 11 years (in primary school) with a diagnosis of autism
2. Family will have spoken English at home which is adequate to allow them potentially to participate in this communication based intervention
Pre-school cohort:
1. Aged 2 years to 4 years 11 months
2. Meeting criteria for core autism on 2 from 3 modules of Autism Diagnostic Observation Schedule (ADOS2) the Autism Diagnostic Interview Revised (ADIR)
3. Parents using spoken English at home
4. Above 12 months equivalent level in general (non language) development.
School age cohort:
1. Aged 5 to 11 years
2. In primary school for length of participation in study
3. Meeting criteria for ASD on the Autism Diagnostic Observation Schedule (ADOS2) and Social Communication Questionnaire (SCQ)
4. Developmentally from the beginning of intentional language to the beginning of fluent speech
Participant type
Patient
Age group
Child
Gender
Both
Target number of participants
Planned Sample Size: 24 in External pilot phase and 244 in main RCT; UK Sample Size: 24 and 244
Participant exclusion criteria
1. Having a sibling with autism already in the trial
2. Only one child with autism per family can be included
3. Seizures uncontrolled by medication
4. Neither child or parent will have long term severe hearing or visual impairment that would limit participation in the intervention
5. Current clinically severe psychiatric illness in parents
Recruitment start date
01/07/2016
Recruitment end date
31/12/2016
Locations
Countries of recruitment
United Kingdom
Trial participating centre
University of Manchester
Room 3.316, Jean McFarlane Building
Oxford Road
Manchester
M13 9PT
United Kingdom
Funders
Funder type
Government
Funder name
National Institute for Health Research
Alternative name(s)
NIHR
Funding Body Type
government organisation
Funding Body Subtype
Federal/National Government
Location
United Kingdom
Results and Publications
Publication and dissemination plan
Not provided at time of registration
Intention to publish date
Participant level data
Not provided at time of registration
Results - basic reporting
Publication summary